Katharina Schmidt-Bleek

Dr. Katharina Schmidt-Bleek

Julius Wolff Institute for Biomechanics and Musculoskeletal Regeneration, Charité - Universitätsmedizin Berlin
orcid

Research Focus & Metrics

Academic Career Length

30Years (1997-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2018 in Bone
Verified
Journal Article
Closed access
CSClaudia Schlundt
Claudia Schlundt
TKThaqif El Khassawna
Thaqif El Khassawna
ASAlessandro Serra
Alessandro Serra
ADAnke Dienelt
Anke Dienelt
SWSebastian Wendler
Sebastian Wendler
KSKatharina Schmidt-Bleek
Katharina Schmidt-Bleek

1 March 2018 in Bone & Joint Research
Verified
Journal Article
Open access
TWT. Winkler
T. Winkler
FSF Andrea Sass
F Andrea Sass
GDGeorg Duda
Georg Duda
KSKatharina Schmidt-Bleek
Katharina Schmidt-Bleek
Despite its intrinsic ability to regenerate form and function after injury, bone tissue can be challenged by a multitude of pathological conditions. While innovative approaches have helped to unravel the cascades of bone healing, this knowledge has so far not improved the clinical outcomes of bone defect treatment. Recent findings have allowed us to gain in-depth knowledge about the physiological conditions and biological principles of bone regeneration. Now it is time to transfer the lessons learned from bone healing to the challenging scenarios in defects and employ innovative technologies to enable biomaterial-based strategies for bone defect healing. This review aims to provide an overview on endogenous cascades of bone material formation and how these are transferred to new perspectives in biomaterial-driven approaches in bone regeneration. Cite this article: T. Winkler, F. A. Sass, G. N. Duda, K. Schmidt-Bleek. A review of biomaterials in bone defect healing, remaining shortcomings and future opportunities for bone tissue engineering: The unsolved challenge. Bone Joint Res 2018;7:232–243. DOI: 10.1302/2046-3758.73.BJR-2017-0270.R1.

9 January 2023 in Nature Reviews Rheumatology
Verified
Journal Article
Closed access
PDF file
GDGeorg Duda
Georg Duda
SGSven Geissler
Sven Geissler
SCSara Checa
Sara Checa
STSerafeim Tsitsilonis
Serafeim Tsitsilonis
APAnsgar Petersen
Ansgar Petersen
KSKatharina Schmidt-Bleek
Katharina Schmidt-Bleek

1 October 2021 in Acta Biomaterialia
Verified
Journal Article
Closed access
CSClaudia Schlundt
Claudia Schlundt
HFHeilwig Fischer
Heilwig Fischer
CBChristian H. Bucher
Christian H. Bucher
CRCarsten Rendenbach
Carsten Rendenbach
GDGeorg Duda
Georg Duda
KSKatharina Schmidt-Bleek
Katharina Schmidt-Bleek

1 August 2010 in Tissue Engineering Part B: Reviews
Verified
Journal Article
Closed access
PKPaula Kolar
Paula Kolar
KSKatharina Schmidt-Bleek
Katharina Schmidt-Bleek
HSHanna Schell
Hanna Schell
Timo GaberTimo Gaber
Timo Gaber
DTDaniel Toben
Daniel Toben
GDGeorg N. Duda
Georg N. Duda
Research regarding the potency and potential of the fracture hematoma has begun to receive increasing attention. However, currently there is a paucity of relevant literature on the capability and composition of the fracture hematoma. This review briefly summarizes the regenerative fracture healing process and the close interplay between the skeletal and immune systems. The role of immune cells in wound healing is also discussed to clarify their involvement in immunological processes during regeneration. We attempt to describe the current state of knowledge regarding the fracture hematoma as the initial stage of the regenerative process of fracture healing. The review discusses how a better understanding of immune reactions in the hematoma may have implications for bone tissue engineering strategies. We conclude the review by emphasizing how additional investigations of the initial phase of healing will allow us to better differentiate between deleterious and beneficial aspects of inflammation, thereby facilitating improved fracture treatment strategies.

20 March 2013 in Science Translational Medicine
Verified
Journal Article
Closed access
PDF file
SRSimon Reinke
Simon Reinke
SGSven Geissler
Sven Geissler
William R. TaylorWilliam R. Taylor
William R. Taylor
KSKatharina Schmidt-Bleek
Katharina Schmidt-Bleek
KJKerstin Juelke
Kerstin Juelke
GDGeorg N. Duda
Georg N. Duda
There is growing evidence that adaptive immunity contributes to endogenous regeneration processes: For example, endogenous bone fracture repair is modulated by T cells even in the absence of infection. Because delayed or incomplete fracture healing is associated with poor long-term outcomes and high socioeconomic costs, we investigated the relationship between an individual’s immune reactivity and healing outcome. Our study revealed that delayed fracture healing significantly correlated with enhanced levels of terminally differentiated CD8+ effector memory T (TEMRA) cells (CD3+CD8+CD11a++CD28−CD57+ T cells) in peripheral blood. This difference was long lasting, reflecting rather the individual’s immune profile in response to lifelong antigen exposure than a post-fracture reaction. Moreover, CD8+ TEMRA cells were enriched in fracture hematoma; these cells were the major producers of interferon-γ/tumor necrosis factor–α, which inhibit osteogenic differentiation and survival of human mesenchymal stromal cells. Accordingly, depletion of CD8+ T cells in a mouse osteotomy model resulted in enhanced endogenous fracture regeneration, whereas a transfer of CD8+ T cells impaired the healing process. Our data demonstrate the high impact of the individual adaptive immune profile on endogenous bone regeneration. Quantification of CD8+ TEMRA cells represents a potential marker for the prognosis of the healing outcome and opens new opportunities for early and targeted intervention strategies.